Skip to main content
SpringerLink
Log in

Outcomes in Lymphoma Patients with Obstructive Jaundice: A Cancer Center Experience

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Little information is available to guide clinicians on the optimal approach to managing obstructive jaundice in lymphoma patients.

Aims

The aim of this study was to review our experience in treating lymphoma patients with obstructive jaundice in order to develop guidelines as to the best interventional approach.

Methods

We reviewed the medical records of all lymphoma patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous biliary drainage (PBD) for obstructive jaundice between June 2002 and October 2008.

Results

We identified 35 lymphoma patients who underwent ERCP and/or PBD for obstructive jaundice. The mean age was 57.6 years. Most patients (66%) had diffuse large B-cell lymphoma. Stents were placed by ERCP in 25 patients and PBD in nine. Serum bilirubin levels normalized following ERCP or PBD in 29 of 33 (85%) patients with stricture. Stricture resolution occurred in 12 cases. Patients who had obstructive jaundice at the time of their lymphoma diagnosis had significantly longer mean overall survival following intervention than patients in whom obstructive jaundice developed later in the course of their disease (21.3 months vs. 4.5 months, P = 0.0001).

Conclusions

ERCP and/or PBD effectively normalized serum bilirubin levels. Plastic stents should be used in patients who have obstructive jaundice at the time of lymphoma diagnosis because these strictures tend to resolve before stent exchanges are necessary. For patients in whom obstructive jaundice develops later in the course of their disease, the limited prognosis often makes a single intervention with insertion of a plastic stent sufficient to provide adequate biliary decompression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer. 2002;94:2015–2023.

    Article  PubMed  Google Scholar 

  2. Friedberg JW, Mauch PM, Rimsza LM, Fisher RI. Non-Hodgkin’s lymphomas. In: Devita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008:2098–2143.

    Google Scholar 

  3. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from non-Hodgkin’s lymphomas. Leuk Res. 2002;26:903–908.

    Article  PubMed  Google Scholar 

  4. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84:1–12.

    Article  PubMed  Google Scholar 

  5. Tchambaz L, Schlatter C, Jakob M, et al. Dose adaptation of antineoplastic drugs in patients with liver disease. Drug Saf. 2006;29:509–522.

    Article  CAS  PubMed  Google Scholar 

  6. Ghobrial IM, Wolf RC, Pereira DL, et al. Therapeutic options in patients with lymphoma and severe liver dysfunction. Mayo Clin Proc. 2004;79:169–175.

    Article  CAS  PubMed  Google Scholar 

  7. Wasan SM, Ross WA, Staerkel GA, Lee JH. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol. 2005;100:2056–2061.

    Article  PubMed  Google Scholar 

  8. Schmassmann A, von Gunten E, Knuchel J, et al. Wall stents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol. 1996;91:654–659.

    CAS  PubMed  Google Scholar 

  9. Yoon WJ, Ryu JK, Yang KY, et al. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost. Gastrointest Endosc. 2009;70:284–289.

    Article  Google Scholar 

  10. Shah RJ, Howell DA, Desilets DJ, et al. Multicenter randomized trial of the spiral Z-stent compared with the wall stent for malignant biliary obstruction. Gastrointest Endosc. 2003;57:830–836.

    Article  PubMed  Google Scholar 

  11. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–734.

    Article  CAS  PubMed  Google Scholar 

  12. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.

    Article  CAS  PubMed  Google Scholar 

  13. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249.

    Article  PubMed  Google Scholar 

  14. Odemis B, Parlak E, Basar O, Yuksel O, Sahin B. Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center. Dig Dis Sci. 2007;52:2323–2332.

    Article  PubMed  Google Scholar 

  15. Moser EC, Noordijk EM, van Leeuwen FE, et al. Risk of second cancer after treatment of aggressive non-Hodgkin’s lymphoma; an EORTC cohort study. Haematologica. 2006;91:1481–1488.

    PubMed  Google Scholar 

  16. Sacchi S, Marcheselli L, Bari A, et al. Second malignancies after treatment of diffuse large B-cell non-Hodgkin’s lymphoma: a GISL cohort study. Haematologica. 2008;93:1335–1342.

    Article  PubMed  Google Scholar 

  17. Nishimura R, Takakuwa T, Hoshida Y, Tsujimoto M, Aozasa K. Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature. Oncology. 2001;60:322–329.

    Article  CAS  PubMed  Google Scholar 

  18. Peter U, Honegger H, Koelz HR. Obstructive jaundice caused by primary duodenal lymphoma. Case report and review of the literature. Digestion. 2007;75:124–125.

    Article  PubMed  Google Scholar 

  19. Das K, Fisher A, Wilson DJ, et al. Primary non-Hodgkin’s lymphoma of the bile ducts mimicking cholangiocarcinoma. Surgery. 2003;134:496–500.

    Article  PubMed  Google Scholar 

  20. Caraway NP. Strategies to diagnose lymphoproliferative disorders by fine-needle aspiration by using ancillary studies. Cancer. 2005;105:432–442.

    Article  PubMed  Google Scholar 

  21. Jorgensen JL. State of the art symposium: flow cytometry in the diagnosis of lymphoproliferative disorders by fine-needle aspiration. Cancer. 2005;105:443–451.

    Article  PubMed  Google Scholar 

  22. Ravindra KV, Stringer MD, Prasad KR, Kinsey SE, Lodge JP. Non-Hodgkin lymphoma presenting with obstructive jaundice. Br J Surg. 2003;90:845–849.

    Article  CAS  PubMed  Google Scholar 

  23. Dudgeon DJ, Brower M. Primary chemotherapy for obstructive jaundice caused by intermediate-grade non-Hodgkin lymphoma. Cancer. 1993;71:2813–2816.

    Article  CAS  PubMed  Google Scholar 

  24. Pinol V, Castells A, Bordas JM, et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology. 2002;225:27–34.

    Article  PubMed  Google Scholar 

  25. Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2:57–62.

    Article  CAS  PubMed  Google Scholar 

  26. Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47:1–7.

    Article  CAS  PubMed  Google Scholar 

  27. Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33:213–221.

    Article  PubMed  Google Scholar 

  28. Winick AB, Waybill PN, Venbrux AC. Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol. 2001;4:200–206.

    Article  CAS  PubMed  Google Scholar 

  29. Fidias P, Carey RW, Grossbard ML. Non-Hodgkin’s lymphoma presenting with biliary tract obstruction. A discussion of seven patients and a review of the literature. Cancer. 1995;75:1669–1677.

    Article  CAS  PubMed  Google Scholar 

  30. Boddie AW Jr, Eisenberg BL, Mullins JD, Schlichtemeier AL. The diagnosis and treatment of obstructive jaundice secondary to malignant lymphoma: a problem in multidisciplinary management. J Surg Oncol. 1980;14:111–123.

    Article  PubMed  Google Scholar 

  31. Feller E, Schiffman FJ. Extrahepatic biliary obstruction by lymphoma. Arch Surg. 1990;125:1507–1509.

    CAS  PubMed  Google Scholar 

  32. Birrer MJ, Young RC. Differential diagnosis of jaundice in lymphoma patients. Semin Liver Dis. 1987;7:269–277.

    Article  CAS  PubMed  Google Scholar 

  33. Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol. 2004;124:151–159.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

None

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Hepatology and Nutrition, Unit 1466, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA

    William A. Ross, Chukwuma I. Egwim & Jeffrey H. Lee

  2. Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

    Michael J. Wallace & David C. Madoff

  3. Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

    Michael Wang

Authors
  1. William A. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chukwuma I. Egwim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David C. Madoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jeffrey H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William A. Ross.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, W.A., Egwim, C.I., Wallace, M.J. et al. Outcomes in Lymphoma Patients with Obstructive Jaundice: A Cancer Center Experience. Dig Dis Sci 55, 3271–3277 (2010). https://doi.org/10.1007/s10620-010-1310-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-010-1310-6

Keywords

Search

Navigation